Patent 7862840 was granted and assigned to Omnica Limited on January, 2011 by the United States Patent and Trademark Office.
The invention describes the preparation, isolation and use of an extract of kiwi fruit for the treatment of a disease or condition related with, caused by or mediated by activity of human pancreatic lipase and/or human fatty acid synthase.